Investor Presentation Full Year 2017
Investor Presentation
Full year 2017
The GLP-1 segment accounts for 12% of the global
diabetes care market value
Slide 63
Global GLP-1 market
GLP-1 value
in bDKK
VictozaⓇ
exenatide
-dulaglutide Share of total
other
diabetes care
Share of total
diabetes care
market
market
GLP-1 value and patient share of the total
diabetes care market
GLP-1 value share of total diabetes
GLP-1 patient share¹ of total diabetes
70
10%
15%
14%
60
12%
8%
CAGR value¹: 33.0%
11%
50
10%
40
6%
30-
20
10
0
Nov
2012
6%
5%
4%
5%
5%
5%
3%
2%
0%
0%
Nov
2017
World North Reg Reg Reg Reg Reg
America EU AAMEO J&K LATAM China
1%
1 CAGR for 5-year period
Source: IQVIA (formerly IMS) monthly MAT Nov, 2017 value figures (DKK)
changing
diabetes®
Reg: Region; AAMEO: Africa, Asia, Middle-East and Oceania; J&K: Japan & Korea; LATAM: Latin America.
1 Patient share is indicative and based on data for US, UK, Germany and France only.
Source: Value data; IQVIA (formerly IMS) monthly MAT Nov, 2017. Patient data; IQVIA Disease Analyser
(DE, FR, UK), QuintilesIQVIA LRX (USA), Aug 2017View entire presentation